Provides pharmacy benefit management services, including retail drug card programs, mail pharmacy services, drug formulary management programs and other clinical management programs for HMOs, health insurers, third-party administrators and employers.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Express Scripts is in a great position to take advantage of the aging population which will is in greater and greater need for regular maintenance medications, which falls right into their mail-order strategy. Increasing Revenue and EPS over the last 5 years shows that Express Scripts has the leadership and direction to keep growing for years to come.
ESRX has been bouncing between support at 52 and resistance at 60 since January. ESRX is definitely a thumbs-up company, however, I suggest waiting until the stock approaches 52 before initiating any positions. I don't think its very likely that the stock with slide lower than 52 before bouncing back, but the cautious and responsible investor will wait for an obvious up-trend around 52 before buying. Look for the stock to eventually have a break-out rally going above 60, if this happens BUY. Don't forget to decide on a responsible exit point before you initiate your position. A good exit point limits your losses while your upside remains unlimited (technically). I have thumbs-up on ESRX for the foreseeable future.